X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10027) 10027
Publication (904) 904
Book Review (139) 139
Book Chapter (42) 42
Magazine Article (24) 24
Conference Proceeding (13) 13
Dissertation (12) 12
Government Document (3) 3
Reference (3) 3
Book / eBook (2) 2
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (5638) 5638
humans (5174) 5174
male (4839) 4839
index medicus (3783) 3783
female (3194) 3194
rats (2706) 2706
cyclooxygenase inhibitors - pharmacology (2197) 2197
mice (2022) 2022
cyclooxygenase 2 - metabolism (1780) 1780
pharmacology & pharmacy (1769) 1769
celecoxib (1573) 1573
cyclooxygenase-2 (1389) 1389
cyclooxygenase inhibitors - administration & dosage (1385) 1385
cyclooxygenase 2 (1378) 1378
adult (1353) 1353
middle aged (1351) 1351
nonsteroidal antiinflammatory drugs (1325) 1325
cox-2 inhibitors (1317) 1317
inflammation (1307) 1307
cyclooxygenase inhibitors - therapeutic use (1241) 1241
dose-response relationship, drug (1225) 1225
cyclooxygenase (1189) 1189
expression (1118) 1118
rats, sprague-dawley (1033) 1033
aged (1017) 1017
rats, wistar (923) 923
cyclooxygenase 2 inhibitors (911) 911
anti-inflammatory agents, non-steroidal - adverse effects (889) 889
cyclooxygenase inhibitors - adverse effects (878) 878
indomethacin - pharmacology (864) 864
anti-inflammatory agents, non-steroidal - therapeutic use (850) 850
cyclooxygenase 2 inhibitors - administration & dosage (848) 848
disease models, animal (845) 845
anti-inflammatory agents, non-steroidal - administration & dosage (840) 840
membrane proteins (823) 823
prostaglandin-endoperoxide synthases - metabolism (813) 813
research (809) 809
prostaglandins (786) 786
cox-2 (778) 778
cyclooxygenase 2 inhibitors - pharmacology (763) 763
inhibition (756) 756
sulfonamides - pharmacology (746) 746
cyclooxygenase 2 inhibitors - therapeutic use (740) 740
oncology (738) 738
cyclooxygenase 2 - genetics (727) 727
anti-inflammatory agents, non-steroidal - pharmacology (715) 715
time factors (712) 712
physiology (706) 706
treatment outcome (700) 700
cyclooxygenase inhibitors (695) 695
aspirin (689) 689
indomethacin (657) 657
sulfonamides - administration & dosage (649) 649
administration, oral (630) 630
double-blind method (620) 620
nitric oxide (616) 616
risk factors (588) 588
dinoprostone - metabolism (582) 582
cancer (577) 577
analysis (567) 567
biochemistry & molecular biology (559) 559
neurosciences (557) 557
cyclooxygenase 2 inhibitors - adverse effects (550) 550
apoptosis (546) 546
rodents (546) 546
nonsteroidal anti-inflammatory drugs (539) 539
rheumatoid-arthritis (538) 538
isoenzymes - antagonists & inhibitors (533) 533
care and treatment (524) 524
sulfonamides - therapeutic use (520) 520
nitric-oxide (511) 511
immunology (498) 498
research article (494) 494
health aspects (490) 490
nitric-oxide synthase (488) 488
aspirin - administration & dosage (487) 487
isoenzymes - metabolism (484) 484
physiological aspects (481) 481
cells (476) 476
dosage and administration (470) 470
mice, inbred c57bl (469) 469
rofecoxib (466) 466
pain (454) 454
pyrazoles - pharmacology (453) 453
oxidative stress (442) 442
activation (435) 435
medicine (435) 435
cell biology (434) 434
prevention (430) 430
medicine, general & internal (429) 429
enzyme inhibitors - pharmacology (422) 422
pyrazoles - administration & dosage (421) 421
rat (415) 415
drug therapy (414) 414
article (404) 404
osteoarthritis (404) 404
surgery (403) 403
immunohistochemistry (402) 402
risk (402) 402
aspirin - pharmacology (401) 401
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9682) 9682
German (102) 102
Japanese (51) 51
French (48) 48
Russian (42) 42
Chinese (35) 35
Spanish (29) 29
Norwegian (18) 18
Danish (15) 15
Swedish (14) 14
Italian (13) 13
Polish (12) 12
Ukrainian (6) 6
Bulgarian (5) 5
Czech (5) 5
Dutch (5) 5
Hungarian (5) 5
Korean (4) 4
Portuguese (3) 3
Turkish (3) 3
Hebrew (2) 2
Slovak (2) 2
Croatian (1) 1
Finnish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 11/2003, Volume 290, Issue 18, pp. 2411 - 2418
Journal Article
Depression and Anxiety, ISSN 1091-4269, 07/2009, Volume 26, Issue 7, pp. 607 - 611
Journal Article
Circulation, ISSN 0009-7322, 01/2013, Volume 127, Issue 3, pp. 377 - 385
Background-Low dose aspirin reduces the secondary incidence of myocardial infarction and stroke. Drug resistance to aspirin might result in treatment failure.... 
aspirin | blood platelets | pharmacology | thromboxanes | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | HEALTHY-SUBJECTS | INTERINDIVIDUAL VARIABILITY | PLATELET-FUNCTION | THROMBOXANE BIOSYNTHESIS | VASCULAR-DISEASE | INHIBITION | LOW-DOSE ASPIRIN | CYCLOOXYGENASE ACTIVITY | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | Ticlopidine - pharmacology | Humans | Middle Aged | Male | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Platelet Aggregation Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Ticlopidine - administration & dosage | Adult | Female | Aspirin - therapeutic use | Platelet Aggregation - drug effects | Aspirin - pharmacology | Platelet Aggregation Inhibitors - therapeutic use | Drug Resistance | Stroke - prevention & control | Administration, Oral | Cyclooxygenase Inhibitors - administration & dosage | Treatment Outcome | Ticlopidine - analogs & derivatives | Cyclooxygenase Inhibitors - pharmacology | Cross-Over Studies | Adolescent | Cyclooxygenase 1 - drug effects | Myocardial Infarction - prevention & control | Tablets, Enteric-Coated | Cyclooxygenase Inhibitors - therapeutic use | Stroke (Disease) | Aspirin | Dosage and administration | Genetic aspects | Research | Drug therapy | Drug resistance | Health aspects | Heart attack | thromboxane | platelets
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2006, Volume 355, Issue 9, pp. 873 - 884
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2015, Volume 107, Issue 1, p. 345
Journal Article
Journal of Immunology, ISSN 0022-1767, 03/2010, Volume 184, Issue 5, pp. 2449 - 2457
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 07/2006, Volume 11, Issue 7, pp. 680 - 684
Signs of an inflammatory process, in particular increased pro-inflammatory cytokines and increased levels of prostaglandine E-2 ( PGE(2)), have repeatedly been... 
COX-2 inhibition | Inflammation | Psychoneuroimmunology | Major depression | Immunity | SYSTEM | COX-2 | PSYCHIATRY | BIOCHEMISTRY & MOLECULAR BIOLOGY | psychoneuroimmunology | SCHIZOPHRENIA | SICKNESS BEHAVIOR | SYMPTOMS | immunity | NEUROSCIENCES | INFLAMMATORY MARKERS | INTERFERON-ALPHA | PROSTAGLANDINS | inflammation | ROFECOXIB | major depression | BRAIN | Anti-Anxiety Agents - administration & dosage | Dinoprostone - analysis | Pyrazoles - therapeutic use | Adrenergic Uptake Inhibitors | Dinoprostone - biosynthesis | Humans | Middle Aged | Depressive Disorder - drug therapy | Male | Patient Dropouts | Lorazepam - therapeutic use | Inflammation - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Adult | Female | Antidepressive Agents - pharmacology | Anti-Anxiety Agents - therapeutic use | Drug Therapy, Combination | Morpholines - therapeutic use | Pyrazoles - pharmacology | Severity of Illness Index | Cyclooxygenase 2 Inhibitors - pharmacology | Double-Blind Method | Cyclooxygenase 2 Inhibitors - administration & dosage | Morpholines - administration & dosage | Lorazepam - administration & dosage | Celecoxib | Sulfonamides - pharmacology | Antidepressive Agents - therapeutic use | Pilot Projects | Pyrazoles - administration & dosage | Sulfonamides - therapeutic use | Depressive Disorder - physiopathology | Serotonin - metabolism | Interleukin-6 - biosynthesis | Antidepressive Agents - administration & dosage | Psychological Tests | Sulfonamides - administration & dosage | Inflammation - physiopathology
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10087, pp. 2375 - 2382
Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require... 
Internal Medicine | RHEUMATOID-ARTHRITIS | CYCLO-OXYGENASE-2 | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY | DICLOFENAC | PREVENTION | RISK | OSTEOARTHRITIS | Celecoxib - administration & dosage | Recurrence | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Secondary Prevention - methods | Aspirin - administration & dosage | Cyclooxygenase 2 Inhibitors - adverse effects | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Naproxen - administration & dosage | Cyclooxygenase 2 Inhibitors - therapeutic use | Peptic Ulcer Hemorrhage - prevention & control | Aged, 80 and over | Aspirin - therapeutic use | Drug Therapy, Combination | Celecoxib - adverse effects | Naproxen - adverse effects | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Cyclooxygenase 2 Inhibitors - administration & dosage | Peptic Ulcer Hemorrhage - chemically induced | Celecoxib - therapeutic use | Proton Pump Inhibitors - therapeutic use | Naproxen - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Arthritis - drug therapy | Aged | Care and treatment | Aspirin | Anti-inflammatory drugs | Gastrointestinal diseases | Naproxen | Clinical trials | Arthritis | Complications and side effects | Medical research | Gastrointestinal bleeding | Medicine, Experimental | Drugs | Funding | Risk | Population studies | Hemorrhage | Bleeding | Incidence | Prostaglandin endoperoxide synthase | Motivation | Safety | Nonsteroidal anti-inflammatory drugs | Antiinflammatory agents | Digestive system | Risk reduction | Inflammation | Celecoxib | Patients | Diseases | Omeprazole | Random numbers | Inhibitors | Ulcers | Healing | Fatalities | Cyclooxygenase-2 | Cardiovascular diseases | Health risk assessment
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2005, Volume 352, Issue 11, pp. 1071 - 1080
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 10/2007, Volume 96, Issue 10, pp. 2686 - 2702
Journal Article